This ASX 200 healthcare share has a fully franked dividend yield over 4% right now

This ASX 200 healthcare share offers a dividend yield over 4% right now…

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points
  • The ASX 200 is home to many dividend-paying shares
  • But not too many healthcare shares offer high dividend yields today
  • But let's look at one that is boasting a 4% yield right now...

Sure there are a lot of ASX dividend shares on the S&P/ASX 200 Index (ASX: XJO) to choose from. There are the big banks like Commonwealth Bank of Australia (ASX: CBA). Then there are the mining giants like BHP Group Ltd (ASX: BHP). Other dividend investors look to blue-chips like Telstra Corporation Ltd (ASX: TLS), or Wesfarmers Ltd (ASX: WES) for income. But dividend-paying ASX healthcare shares?

Traditionally, the healthcare space is not one where many investors traditionally search for income. The market's largest healthcare share is CSL Limited (ASX: CSL). But even though CSL shares have fallen more than 8% this year so far, the company still has a dividend yield under 1%.

But there is a healthcare share on the ASX that currently offers a fully franked dividend yield of over 4% right now. That would be Medibank Private Ltd (ASX: MPL).

Medibank Private is the ASX's largest healthcare insurer. Many of us would know its flagship Medibank brand, as well as its AHM subsidiary.

Well, right now, Medibank Private shares offer a dividend yield of 4.06%. Since this yield comes fully franked too, it grosses up to a meaty 5.8% with those franking credits. 

Stethoscope with a piggy bank and hundred dollar notes.

Image source: Getty Images

How do Medibank shares offer a 4% yield today?

Where does this yield come from? Well, Medibank's last two dividend payments. The company paid out its interim dividend for FY2022 last month This was a payment of 6.2 cents per share, a healthy rise on the previous interim dividend of 5.8 cents per share. Before that, Medibank doled out a final dividend of 6.9 cents per share in September last year. Again, that was an increase on its 2020 final payment of 6.3 cents per share.

Medibank actually had a bit of a streak going before COVID. From its first ever dividend in 2015, Medibank gave its investors an annual dividend pay raise every year until 2019. 2019 saw the company payout 15.6 cents per share in dividends, but this was reduced to 12 cents in 2020 largely thanks to the effects of the pandemic. 2021 saw the company begin to increase its shareholder payouts once again, which it has continued to do in 2022 so far.

So that's how we get to a 4.06% yield for Medibank shares today. Not too common for an ASX healthcare share at all.

At the current Medibank Private share price, this ASX 200 healthcare share has a market capitalisation of $8.81 billion. 

Motley Fool contributor Sebastian Bowen has positions in Telstra Corporation Limited. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended CSL Ltd. The Motley Fool Australia has positions in and has recommended Telstra Corporation Limited and Wesfarmers Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

Medical workers examine an x-ray or scan in a hospital laboratory.
Healthcare Shares

This ASX biotech has just announced a major US deal

This company's heart disease technology is gaining traction.

Read more »

Devastated woman sits near smartphone on home kitchen floor troubled with loneliness.
Healthcare Shares

Which beaten down ASX healthcare stock is a better buy right now: Pro Medicus vs Cochlear shares

Which do experts prefer?

Read more »

Health professional working on his laptop.
Healthcare Shares

Already up 42% this year, Morgans says this ASX healthcare stock can continue to rocket

This broker sees big upside for this healthcare stock.

Read more »

Medical workers examine an x-ray or scan in a hospital laboratory.
Healthcare Shares

This ASX small-cap healthcare stock could rocket more than 50%: Morgans

Share price weakness could present an opportunity.

Read more »

Male doctor in a lab coat working at laptop looking serious.
Healthcare Shares

Guess which ASX 300 stock was given a big boost from the US FDA

This healthcare stock has made a positive announcement today.

Read more »

A man in a business suit rides a graphic image of an arrow that is rebounding on a graph.
Broker Notes

Down 43% this week, are Cochlear shares now the best bargain buy of the year?

A leading analyst believes the historic selloff in Cochlear shares could present a unique buying opportunity.

Read more »

Young businesswoman sitting in kitchen and working on laptop.
Healthcare Shares

Down 50%, why I'd invest $20,000 into CSL shares

A 50% decline in a blue-chip share can signal trouble, but not always a broken story.

Read more »

Female scientist working in a laboratory.
Healthcare Shares

This ASX biotech stock could deliver 40%-plus returns Morgans says

This small company continues to kick goals.

Read more »